These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 30150091)

  • 1. Conservative management of reproductive cancers. Ovarian protection during treatment.
    Cui W; Phillips KA
    Best Pract Res Clin Obstet Gynaecol; 2019 Feb; 55():49-58. PubMed ID: 30150091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preventing ovarian failure associated with chemotherapy.
    Cui W; Stern C; Hickey M; Goldblatt F; Anazodo A; Stevenson WS; Phillips KA
    Med J Aust; 2018 Nov; 209(9):412-416. PubMed ID: 30376664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gonadotropin-Releasing Hormone Agonist Cotreatment During Chemotherapy May Increase Pregnancy Rate in Survivors.
    Blumenfeld Z; Zur H; Dann EJ
    Oncologist; 2015 Nov; 20(11):1283-9. PubMed ID: 26463871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gonadotropin-Releasing Hormone Agonists for Ovarian Function Preservation in Premenopausal Women Undergoing Chemotherapy for Early-Stage Breast Cancer: A Systematic Review and Meta-analysis.
    Munhoz RR; Pereira AA; Sasse AD; Hoff PM; Traina TA; Hudis CA; Marques RJ
    JAMA Oncol; 2016 Jan; 2(1):65-73. PubMed ID: 26426573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of chemotherapy-induced ovarian damage in breast cancer patients.
    Codacci-Pisanelli G; Del Pup L; Del Grande M; Peccatori FA
    Crit Rev Oncol Hematol; 2017 May; 113():90-96. PubMed ID: 28427528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gonadotropin-releasing hormone agonists for ovarian protection during cancer chemotherapy: systematic review and meta-analysis.
    Senra JC; Roque M; Talim MCT; Reis FM; Tavares RLC
    Ultrasound Obstet Gynecol; 2018 Jan; 51(1):77-86. PubMed ID: 29055060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gonadotropin-Releasing Hormone Agonists During Chemotherapy for Preservation of Ovarian Function and Fertility in Premenopausal Patients With Early Breast Cancer: A Systematic Review and Meta-Analysis of Individual Patient-Level Data.
    Lambertini M; Moore HCF; Leonard RCF; Loibl S; Munster P; Bruzzone M; Boni L; Unger JM; Anderson RA; Mehta K; Minton S; Poggio F; Albain KS; Adamson DJA; Gerber B; Cripps A; Bertelli G; Seiler S; Ceppi M; Partridge AH; Del Mastro L
    J Clin Oncol; 2018 Jul; 36(19):1981-1990. PubMed ID: 29718793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preservation of gonadal function in women undergoing chemotherapy: a review of the potential role for gonadotropin-releasing hormone agonists.
    Hickman LC; Valentine LN; Falcone T
    Am J Obstet Gynecol; 2016 Oct; 215(4):415-22. PubMed ID: 27422055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gonadotropin-Releasing Hormone Analogs for Gonadal Protection During Gonadotoxic Chemotherapy: A Systematic Review and Meta-Analysis.
    Sofiyeva N; Siepmann T; Barlinn K; Seli E; Ata B
    Reprod Sci; 2019 Jul; 26(7):939-953. PubMed ID: 30270741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of gonadotropin-releasing hormone agonists for fertility preservation in young breast cancer patients: the benefit remains uncertain.
    Turner NH; Partridge A; Sanna G; Di Leo A; Biganzoli L
    Ann Oncol; 2013 Sep; 24(9):2224-35. PubMed ID: 23709175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological methods for ovarian function and fertility preservation in women with cancer: A literature review.
    Cvetanovic AS; Lambertini M; Punie K; Matovina Brko GG; Zivkovic ND; Popovic MJ; Milovic Kovacevic MM; Popovic LS
    Oncol Res; 2024; 32(8):1309-1322. PubMed ID: 39055889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective study to optimize care and improve knowledge on ovarian function and/or fertility preservation in young breast cancer patients: Results of the pilot phase of the PREgnancy and FERtility (PREFER) study.
    Lambertini M; Fontana V; Massarotti C; Poggio F; Dellepiane C; Iacono G; Abate A; Miglietta L; Ferreccio C; Pescio MC; Conte B; Blondeaux E; Bighin C; D'Alonzo A; Vaglica M; Zanardi E; Boccardo F; Ballestrero A; Anserini P; Del Mastro L
    Breast; 2018 Oct; 41():51-56. PubMed ID: 30007268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in breast cancer patients.
    Conte B; Del Mastro L
    Minerva Ginecol; 2017 Aug; 69(4):350-356. PubMed ID: 28398024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility and efficacy of gonadotropin-releasing hormone agonists for the prevention of chemotherapy-induced ovarian insufficiency in patients with malignant ovarian germ cell tumours (KGOG 3048R).
    Choi MC; Chung YS; Lee JW; Kwon BS; Park BK; Kim SI; Shim SH; Lee KB; Seong SJ; Lee SJ; Lee SH; Yoo HJ; Song T; Kim MK; Baek MH; Kang S; Kim YM
    Eur J Cancer; 2020 Jul; 133():56-65. PubMed ID: 32442924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Premature ovarian failure after chemotherapy for breast cancer].
    Mathelin C; Brettes JP; Diemunsch P
    Bull Cancer; 2008 Apr; 95(4):403-12. PubMed ID: 18495569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can ovarian suppression with gonadotropin-releasing hormone analogs (GnRHa) preserve fertility in cancer patients?
    Rodriguez-Wallberg K; Turan V; Munster P; Oktay K
    Ann Oncol; 2016 Feb; 27(2):357. PubMed ID: 26609009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antral follicle count recovery in women with menses after treatment with and without gonadotropin-releasing hormone agonist use during chemotherapy for breast cancer.
    Sinha N; Letourneau JM; Wald K; Xiong P; Imbar T; Li B; Harris E; Mok-Lin E; Cedars MI; Rosen MP
    J Assist Reprod Genet; 2018 Oct; 35(10):1861-1868. PubMed ID: 30066303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Fertility preservation strategies in young women in case of breast cancer or hematologic malignancy].
    Decanter C; Robin G
    Gynecol Obstet Fertil; 2013 Oct; 41(10):597-600. PubMed ID: 24094596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infertility in reproductive-age female cancer survivors.
    Levine JM; Kelvin JF; Quinn GP; Gracia CR
    Cancer; 2015 May; 121(10):1532-9. PubMed ID: 25649243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategies for fertility preservation in young early breast cancer patients.
    Tomasi-Cont N; Lambertini M; Hulsbosch S; Peccatori AF; Amant F
    Breast; 2014 Oct; 23(5):503-10. PubMed ID: 24934638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.